HIGHLIGHTS
- who: Hyungjin Eoh from the Weill Cornell Medicine, United States University of California, San Francisco have published the paper: Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis, in the Journal: (JOURNAL)
- what: The authors focus on central carbon metabolism (CCM) remodeling during Mtb persister formation as the major mechanism of their adaptive strategy and altered biochemical states (Eoh, 2014; Hartman et_al, 2017; Jansen and Rhee, 2017). The authors discuss how metabolomics technology in antibiotic target identification will improve precision and efficacy of the antibiotic development pipeline . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.